<bill session="114" type="h" number="2428" updated="2018-11-21T21:23:11Z">
  <state datetime="2015-05-19">REFERRED</state>
  <status>
    <introduced datetime="2015-05-19"/>
  </status>
  <introduced datetime="2015-05-19"/>
  <titles>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act with respect to humanitarian device exemption applications.</title>
    <title type="display">To amend the Federal Food, Drug, and Cosmetic Act with respect to humanitarian device exemption applications.</title>
  </titles>
  <sponsor bioguide_id="S000364"/>
  <cosponsors/>
  <actions>
    <action datetime="2015-05-19">
      <text>Introduced in House</text>
    </action>
    <action datetime="2015-05-19" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2015-05-22">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="114" relation="unknown" number="6"/>
    <bill type="s" session="114" relation="unknown" number="2188"/>
    <bill type="h" session="114" relation="unknown" number="34"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Health technology, devices, supplies"/>
  </subjects>
  <amendments/>
  <summary date="2015-05-19T04:00:00Z" status="Introduced in House">This bill amends the Federal Food, Drug, and Cosmetic Act to expand the humanitarian device exemption to authorize the Food and Drug Administration (FDA) to exempt from effectiveness requirements certain medical devices intended to benefit fewer than 8,000 individuals. Currently, the FDA may exempt devices intended to benefit fewer than 4,000 individuals.

Within 18 months of enactment of this Act, the FDA must define &#8220;probable benefit&#8221; for these devices.</summary>
  <committee-reports/>
</bill>
